Drug Addiction in Cancer

This publication has 95 references indexed in Scilit:

• Oncogene addiction as a foundational rationale for targeted anti‐cancer therapy: promises and perils
  EMBO Molecular Medicine, 2011
• Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
  New England Journal of Medicine, 2011
• Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
  Cell, 2009
• Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
  Proceedings of the National Academy of Sciences, 2008
• Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
  Nature, 2008
• Heat Shock Factor 1 Is a Powerful Multifaceted Modifier of Carcinogenesis
  Cell, 2007
• Restoration of p53 function leads to tumour regression in vivo
  Nature, 2007
• Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
  Nature, 2007
• Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
  Nature, 2006
• The Concept of Synthetic Lethality in the Context of Anticancer Therapy
  Nature Reviews Cancer, 2005